Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?

被引：2
|
作者：
Gulin, Dario [1 ,2 ]
Planinic, Zrinka [1 ]
Habek, Jasna Cerkez [1 ,3 ]
Sikic, Jozica [1 ,2 ]
机构：
[1] Univ Hosp Sveti Duh, Dept Cardiovasc Dis, Sveti Duh 64, Zagreb 10000, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
[3] Croatian Catholic Univ, Zagreb, Croatia
来源：
INDIAN JOURNAL OF PHARMACOLOGY | 2019年 / 51卷 / 06期
关键词：
Heart failure; heart transplantation; sacubitril; valsartan; WORKING FORMULATION; NOMENCLATURE; DIAGNOSIS;
D O I：
10.4103/ijp.IJP_562_18
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
We present a case report of a heart failure patient after heart transplantation due to end-stage ischemic cardiomyopathy with significant clinical and echocardiographic improvement 3 months after the introduction of sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor. This new class of drugs is proved to be beneficial in heart failure patients, especially with reduced ejection fraction (HFrEF), but they have not yet been used in heart failure patients after heart transplantation. We believe that the increase of left ventricular systolic function, improvement of global longitudinal strain, and reduction of pulmonary hypertension with consequent clinical recovery in our patient may have been caused by sacubitril/valsartan.
引用
收藏
页码：413 / 415
页数：3
相关论文
共 50 条
  • [41] Long-Term Effects of Angiotensin Receptor-Neprilysin Inhibitors on Myocardial Function in Chronic Heart Failure Patients with Reduced Ejection Fraction
    Poglajen, Gregor
    Anzic-Drofenik, Ajda
    Zemljic, Gregor
    Frljak, Sabina
    Cerar, Andraz
    Okrajsek, Renata
    Sebestjen, Miran
    Vrtovec, Bojan
    [J]. DIAGNOSTICS, 2020, 10 (08)
  • [42] Angiotensin receptor-neprilysin inhibitors for hypertension-hemodynamic effects and relevance to hypertensive heart disease
    Kario, Kazuomi
    Williams, Bryan
    [J]. HYPERTENSION RESEARCH, 2022, 45 (07) : 1097 - 1110
  • [43] Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
    Ryazanov, A. S.
    Shikh, E. V.
    Makarovskaya, M. V.
    Kudryavtsev, A. A.
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2023, 56
  • [44] Angiotensin receptor-neprilysin inhibiton (ARNI) - A novel therapeutic concept for management of hypertension and heart failure
    Kjeldsen, Sverre E.
    Hedner, Thomas
    Narkiewicz, Krzysztof
    Oparil, Suzanne
    [J]. BLOOD PRESSURE, 2012, 21 (06) : 329 - 330
  • [45] Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction
    Park, Dae Yong
    An, Seokyung
    Attanasio, Steve
    Jolly, Neeraj
    Malhotra, Saurabh
    Doukky, Rami
    Samsky, Marc D.
    Sen, Sounok
    Ahmad, Tariq
    Nanna, Michael G.
    Vij, Aviral
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 84 - 92
  • [46] In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial
    Tanaka, Atsushi
    Kida, Keisuke
    Matsue, Yuya
    Imai, Takumi
    Suwa, Satoru
    Taguchi, Isao
    Hisauchi, Itaru
    Teragawa, Hiroki
    Yazaki, Yoshiyuki
    Moroi, Masao
    Ohashi, Koichi
    Nagatomo, Daisuke
    Kubota, Toru
    Ijichi, Takeshi
    Ikari, Yuji
    Yonezu, Keisuke
    Takahashi, Naohiko
    Toyoda, Shigeru
    Toshida, Tsutomu
    Suzuki, Hiroshi
    Minamino, Tohru
    Nogi, Kazutaka
    Shiina, Kazuki
    Horiuchi, Yu
    Tanabe, Kengo
    Hachinohe, Daisuke
    Kiuchi, Shunsuke
    Kusunose, Kenya
    Shimabukuro, Michio
    Node, Koichi
    [J]. EUROPEAN HEART JOURNAL, 2024,
  • [47] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [48] Clinical efficacy of angiotensin-receptor neprilysin inhibitors in the treatment of maintenance hemodialysis with heart failure
    孙长丽
    [J]. China Medical Abstracts (Internal Medicine), 2022, (02) : 114 - 115
  • [49] Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment
    Koichi Yamamoto
    Hiromi Rakugi
    [J]. Hypertension Research, 2021, 44 : 1239 - 1250
  • [50] Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure Registry
    Stolfo, Davide
    Benson, Lina
    Lindberg, Felix
    Dahlstrom, Ulf
    Kack, Oskar
    Sinagra, Gianfranco
    Lund, Lars H.
    Savarese, Gianluigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2024,
12345